Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2026-03-14 @ 1:47 AM
Study NCT ID:
NCT02692703
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2016-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)
Sponsor:
AbbVie
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | HCV Treatment Experienced | View |
| None | Hepatitis C | View |
| None | HCV Genotype 3 | View |
| None | Without cirrhosis | View |
| None | Non-cirrhotic | View |
| None | HCV Genotype 2 | View |
| None | Renal Transplant | View |
| None | HCV Treatment Naive | View |
| None | Post transplant | View |
| None | HCV Genotype 6 | View |
| None | Liver Transplant | View |
| None | HCV Genotype 5 | View |
| None | HCV Genotype 4 | View |
| None | Kidney Transplant | View |
| None | HCV Genotype 1 | View |